Return to homepagePandemic Pact

NECESSITY-New SARS-CoV-2 modulating chem. Constructs

Grant number: I 5406

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $467,264.8

  • Funder

    FWF

  • Principal Investigator

    N/A

  • Research Location

    Austria

  • Lead Research Institution

    Sektion für Biologische Chemie, Medizinische Universität Innsbruck

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Tracking and blocking interdependencies of cellular BRAF-MEK oncokinase activities.